Formulation and In Vitro Studies of a Fixed-Dose Combination of a Bilayer Matrix Tablet Containing M...
Formulation and In Vitro Studies of a Fixed-Dose Combination of a Bilayer Matrix Tablet Containing Metformin HCl as Sustained Release and Glipizide as Immediate Release
About this item
Full title
Author / Creator
Publisher
England: Informa UK Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Informa UK Ltd
Subjects
More information
Scope and Contents
Contents
The emerging new fixed dose combination of metformin hydrocholride (HCl) as sustained release and glipizide as immediate release were formulated as a bilayer matrix tablet using hydroxy propyl methyl cellulose (HPMC) as the matrix-forming polymer, and the tablets were evaluated via in vitro studies. Three different grades of HPMC (HPMC K 4M, HPMC K...
Alternative Titles
Full title
Formulation and In Vitro Studies of a Fixed-Dose Combination of a Bilayer Matrix Tablet Containing Metformin HCl as Sustained Release and Glipizide as Immediate Release
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_70434420
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70434420
Other Identifiers
ISSN
0363-9045
E-ISSN
1520-5762
DOI
10.1080/03639040701657487
